Quaker Chemical SVP reports equity awards in Form 4

Quaker Chemical Corp senior vice president, general counsel and corporate secretary Robert T. Traub reported a series of equity compensation transactions on March 15, 2026.

Rhea-AI Filing Summary

Quaker Chemical Corp senior vice president, general counsel and corporate secretary Robert T. Traub reported a series of equity compensation transactions on March 15, 2026.

He received 1,772 time-based restricted stock units and 1,028 shares of common stock earned from performance stock units granted in 2023, following certification of the company’s adjusted return on invested capital performance. Previously granted RSUs and dividend equivalent rights were also converted into common stock.

In connection with these vestings, 562 shares of common stock were surrendered at $118.45 per share to cover withholding taxes, a non‑market disposition. After these transactions, Traub directly holds 4,351 shares of common stock, and indirectly holds 1,262 shares through a 401(k) plan as of December 31, 2025.

Insider Trade Summary

894 shares exercised/converted

Exercise 10 txns

Insider Traub Robert T

Role SVP, GC & Corp. Sec.

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	343	$0.00	$0.00
Exercise	Restricted Stock Units	534	$0.00	$0.00
Exercise	Dividend Equivalent Rights	17	$0.00	$0.00
Grant/Award	Restricted Stock Units	1,772	$0.00	$0.00
Grant/Award	Common Stock	1,028	$0.00	$0.00
Exercise	Common Stock	343	$0.00	$0.00
Exercise	Common Stock	534	$0.00	$0.00
Exercise	Common Stock	17	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	562	$118.45	$67K
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 3,184 contracts (Direct); Dividend Equivalent Rights — 0 contracts (Direct); Common Stock — 4,351 shares (Direct); Common Stock — 1,262 shares (Indirect, By 401(k))

Footnotes (8)

1. F1. Shares earned upon vesting and settlement of Performance Stock Units (PSUs) awarded on March 15, 2023, upon certification of performance results by the Compensation and Human Resources Committee based on achievement of the adjusted return on invested capital (ROIC) metric, during the three year performance period.
2. F2. Restricted stock units (RSUs) convert into common stock on a one-for-one basis.
3. F3. Dividend equivalent rights (DERs) accrued on reporting person's RSUs granted on March 15, 2024 and March 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the second installment of the 2024 RSU grant and the first installment of the 2025 RSU grant, each vesting on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock.
4. F4. Shares surrendered by reporting person to satisfy withholding tax obligation upon the full or partial vesting of certain restricted stock, PSUs, and RSUs previously granted under the Company's Long-Term Performance Incentive Plan.
5. F5. Information based on reporting person's Plan Statement as of December 31, 2025.
6. F6. On March 15, 2024, the reporting person was granted 1,029 time-based RSUs, vesting in three annual installments beginning on March 15, 2025.
7. F7. On March 15, 2025, the reporting person was granted 1,603 time-based RSUs, vesting in three annual installments beginning on March 15, 2026.
8. F8. Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Quaker Chemical (KWR) report for Robert T. Traub?

Robert T. Traub reported equity compensation activity, including new restricted stock units, vested performance stock units converting into common shares, and related tax-withholding share surrenders. These transactions reflect routine compensation and vesting events rather than open-market buying or selling of Quaker Chemical stock.

How many restricted stock units did the Quaker Chemical (KWR) executive receive?

On March 15, 2026, Traub received 1,772 time-based restricted stock units that vest in future installments. Each RSU represents a contingent right to one share of Quaker Chemical common stock, with dividend equivalent rights accruing as dividends are paid on the company’s common shares over time.

What performance-based shares vested for Quaker Chemical (KWR) executive Robert T. Traub?

Traub received 1,028 shares of Quaker Chemical common stock from performance stock units granted March 15, 2023. These PSUs vested after the compensation committee certified achievement of an adjusted return on invested capital performance metric measured over a three-year performance period ending before March 15, 2026.

Why were 562 Quaker Chemical (KWR) shares surrendered by the executive?

The 562 shares of Quaker Chemical common stock were surrendered at $118.45 per share to satisfy withholding tax obligations. These shares relate to vesting of restricted stock, performance stock units, and restricted stock units, and represent tax-withholding dispositions rather than open-market sales for investment purposes.

How many Quaker Chemical (KWR) shares does Robert T. Traub hold after these transactions?

Following the reported transactions, Traub directly holds 4,351 shares of Quaker Chemical common stock. In addition, he indirectly holds 1,262 shares through a 401(k) plan, based on his plan statement as of December 31, 2025, providing context for his overall equity exposure.

What are dividend equivalent rights in the Quaker Chemical (KWR) Form 4 filing?

Dividend equivalent rights are credits that accumulate on RSUs when Quaker Chemical pays dividends on its common stock. In this filing, 17 rights converted into common shares as related RSUs vested, with each right economically equivalent to one share of Quaker Chemical common stock at settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 05:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Traub Robert T

(Last) (First) (Middle)

901 E. HECTOR STREET

(Street)

CONSHOHOCKEN PA 19428-2380

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QUAKER CHEMICAL CORP [ KWR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, GC & Corp. Sec.

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/15/2026		A		1,028(1)	A	$0	4,019	D
Common Stock	03/15/2026		M		343	A	(2)	4,362	D
Common Stock	03/15/2026		M		534	A	(2)	4,896	D
Common Stock	03/15/2026		M		17	A	(3)	4,913	D
Common Stock	03/15/2026		F		562(4)	D	$118.45	4,351	D
Common Stock								1,262(5)	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	03/15/2026		M			343	(6)	(6)	Common Stock	343	$0	343	D
Restricted Stock Units	(2)	03/15/2026		M			534	(7)	(7)	Common Stock	534	$0	1,069	D
Dividend Equivalent Rights	(3)	03/15/2026		M			17	(3)	03/15/2026	Common Stock	17	(3)	0	D
Restricted Stock Units	(8)	03/15/2026		A		1,772		(8)	(8)	Common Stock	1,772	$0	1,772	D

Explanation of Responses:

1. Shares earned upon vesting and settlement of Performance Stock Units (PSUs) awarded on March 15, 2023, upon certification of performance results by the Compensation and Human Resources Committee based on achievement of the adjusted return on invested capital (ROIC) metric, during the three year performance period.

2. Restricted stock units (RSUs) convert into common stock on a one-for-one basis.

3. Dividend equivalent rights (DERs) accrued on reporting person's RSUs granted on March 15, 2024 and March 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the second installment of the 2024 RSU grant and the first installment of the 2025 RSU grant, each vesting on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock.

4. Shares surrendered by reporting person to satisfy withholding tax obligation upon the full or partial vesting of certain restricted stock, PSUs, and RSUs previously granted under the Company's Long-Term Performance Incentive Plan.

5. Information based on reporting person's Plan Statement as of December 31, 2025.

6. On March 15, 2024, the reporting person was granted 1,029 time-based RSUs, vesting in three annual installments beginning on March 15, 2025.

7. On March 15, 2025, the reporting person was granted 1,603 time-based RSUs, vesting in three annual installments beginning on March 15, 2026.

8. Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.

Remarks:

	Victoria K. Gehris, Attorney-in-Fact for Robert T. Traub	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.